Ladarixin
Modify Date: 2024-01-03 18:32:49
Ladarixin structure
|
Common Name | Ladarixin | ||
|---|---|---|---|---|
| CAS Number | 849776-05-2 | Molecular Weight | 375.34100 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C11H12F3NO6S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LadarixinA novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM. |
| Name | [4-[(2R)-1-(methanesulfonamido)-1-oxopropan-2-yl]phenyl] trifluoromethanesulfonate |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C11H12F3NO6S2 |
|---|---|
| Molecular Weight | 375.34100 |
| Exact Mass | 375.00600 |
| PSA | 126.86000 |
| LogP | 4.09620 |
| UNII-DEH7Q6472O |
| Ladarixin |